About SinoVeda Canada Inc.

SinoVeda Canada Inc. [ˈsaɪ-nəʊ ˈveɪ-də] was co-founded by Dr. Yun Tam and Dr. Nuzhat Tam-Zaman in 2006. Their aim was to bridge the wisdom of natural medicine from around the world with their extensive education in Pharmacokinetics and clinical evaluation. The foundation of SinoVeda Canada Inc. is the patented Pharmaceutical Platform Technology® (PPT®) developed by Dr. Tam that enables the development of multi-active, multi-target pharmaceutical products.

SinoVeda Canada Inc. has two divisions: Research and Development (R&D) and Consumer Health. The R&D team focuses on advancing PPT® in four scientific departments: molecular pharmacology, analytical chemistry, computational engineering and physics, and quality control and quality assurance. The Consumer Health team manages regulatory affairs, the supply chain, product manufacturing, marketing, sales, distribution, exporting, and customer service for SinoVeda’s products.



Dr. Yun Tam

DR. YUN TAM, BS., MSc., Ph.D.


Dr. Tam is former Professor of Pharmaceutical Sciences, University of Alberta; Founder of Kinetana Inc., a listed company on the GEM board of Hong Kong; Lead inventor of PPT; >30 years in drug discovery and development; Five US patents which include 2 worldwide patents; published over 100 papers in refereed journals; Editorial Board member of Journal of Pharmaceutical Sciences and Drug Metabolism and Disposition; Reviewer Editor of Frontiers in Pharmacology, Ethnopharmacology Section and a member of College of Reviewers, Canadian Institute of Health Research.

Dr. Nuzhat Tam-Zaman

DR. NUZHAT TAM-ZAMAN, B.Pharm., M.Pharm., Ph.D.


Dr. Tam-Zaman is a Pharmaceutical scientist trained in pharmacognosy and pharmacokinetics; solely responsible to successfully register 14 products with Non-Prescription Natural Health Products (NNHPD) in Canada; Participated in securing Self-Affirmed GRAS (Generally Regarded As Safe) status for EffectiCal, a product patented worldwide; one patent, 25 peer reviewed articles; Board member and Co-chair of the board of BioAlberta; Scientific Advisory Board Member of Hyasynth Biologicals Inc.


Chairman & Director of Strategic Business Development

Grant Ferrier



Grant Ferrier, B.S. in Conservation & Resource Studies from the University of California, Berkeley, is the Chairman & Director of Strategic Business Development. As a publisher of proprietary market intelligence, business strategist, management consultant, corporate advisor, board member and investor Mr. Ferrier has served the business community from the world’s largest corporations to startups; multi-lateral institutions, government agencies and non-profits; and private equity investors, public equity analysts and investment banks. Founder of Environmental Business International Inc. (EBI), Nutrition Business Journal (NBJ), and Nutrition Capital Network (NCN).




Dr. Feral Temelli, Ph.D.

Dr. Feral Temelli, Ph.D.

World Renowned Supercritical Extraction Scientist

Professor of Food Process Engineering Department of Agricultural, Food and Nutritional Science, University of Alberta.

Dr. Peichun Amy Tsai, Ph.D., P.Eng.

Dr. Peichun Amy Tsai, Ph.D., P.Eng.

In Silico Organ Design

Assistant Professor Canada Research Chair (Tier 2) in Fluids and Interfaces, University of Alberta.

Dr. Jack A. Tuszynski, Ph.D., D.Sc.

Dr. Jack A. Tuszynski, Ph.D., D.Sc.

Co-Inventor of PPT, Data Mining, Analysis and Docking

Professor, Department of Physics; Adjunct Professor, Department of Oncology; Adjunct Professor, Department of Biomedical Engineering; Member, The Li Ka Shing Institute of Virology, University of Alberta.

Dr. Ronald F. Smith, Ph.D., RPF

Dr. Ronald F. Smith, Ph.D., RPF

GACP Plantation

Adjunct professor, Faculty of Forestry & Environmental Management, University of New Brunswick; Certified Good Agricultural Collection Practice (GACP) instructor.